Charles Schwab Investment Management Inc Standard Biotools Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Standard Biotools Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,445,083 shares of LAB stock, worth $4.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,445,083
Previous 847,355 188.55%
Holding current value
$4.47 Million
Previous $1.5 Million 214.81%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$1.42 - $2.35 $2.27 Million - $3.75 Million
1,597,728 Added 188.55%
2,445,083 $4.72 Million
Q2 2024

Aug 12, 2024
BUY
$1.65 - $2.92 $1.21 Million - $2.15 Million
735,771 Added 659.39%
847,355 $1.5 Million
Q1 2024

May 08, 2024
BUY
$1.87 - $2.78 $150,333 - $223,489
80,392 Added 257.73%
111,584 $302,000
Q1 2023

May 11, 2023
BUY
$1.3 - $2.24 $40,549 - $69,870
31,192 New
31,192 $60,000
Q2 2022

Aug 15, 2022
SELL
$1.6 - $3.99 $272,041 - $678,403
-170,026 Reduced 86.24%
27,127 $44,000
Q1 2022

May 13, 2022
BUY
$2.8 - $3.96 $15,926 - $22,524
5,688 Added 2.97%
197,153 $708,000
Q3 2021

Nov 16, 2021
BUY
$5.5 - $7.41 $29,491 - $39,732
5,362 Added 2.88%
191,465 $1.26 Million
Q2 2021

Aug 16, 2021
BUY
$4.35 - $6.35 $1,979 - $2,889
455 Added 0.25%
186,103 $1.15 Million
Q1 2021

May 17, 2021
BUY
$3.94 - $7.09 $16,808 - $30,245
4,266 Added 2.35%
185,648 $840,000
Q4 2020

Feb 16, 2021
BUY
$5.45 - $8.65 $79,853 - $126,739
14,652 Added 8.79%
181,382 $1.09 Million
Q3 2020

Nov 13, 2020
SELL
$4.34 - $11.43 $24,707 - $65,070
-5,693 Reduced 3.3%
166,730 $1.24 Million
Q2 2020

Aug 14, 2020
BUY
$1.85 - $5.29 $11,268 - $32,221
6,091 Added 3.66%
172,423 $692,000
Q1 2020

May 15, 2020
SELL
$1.24 - $4.35 $509 - $1,787
-411 Reduced 0.25%
166,332 $423,000
Q3 2019

Nov 08, 2019
BUY
$4.63 - $12.15 $11,362 - $29,816
2,454 Added 1.49%
166,743 $773,000
Q2 2019

Aug 09, 2019
BUY
$11.49 - $14.17 $897,414 - $1.11 Million
78,104 Added 90.62%
164,289 $2.03 Million
Q1 2019

May 14, 2019
BUY
$8.47 - $14.36 $109,822 - $186,191
12,966 Added 17.71%
86,185 $1.15 Million
Q4 2018

Feb 14, 2019
BUY
$7.18 - $8.83 $96,348 - $118,489
13,419 Added 22.44%
73,219 $632,000
Q3 2018

Nov 13, 2018
BUY
$5.92 - $8.35 $30,192 - $42,585
5,100 Added 9.32%
59,800 $448,000
Q2 2018

Aug 08, 2018
SELL
$4.86 - $6.24 $83,106 - $106,704
-17,100 Reduced 23.82%
54,700 $327,000
Q4 2017

Jan 17, 2018
BUY
$4.46 - $6.45 $70,468 - $101,910
15,800 Added 28.21%
71,800 $423,000
Q3 2017

Nov 13, 2017
BUY
$3.55 - $5.49 $198,800 - $307,440
56,000
56,000 $283,000

Others Institutions Holding LAB

# of Institutions
142
Shares Held
279M
Call Options Held
27.2K
Put Options Held
34.1K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email